Retina Synthesis
By Retina Synthesis
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Retina Synthesis
Category: Education
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 144
Description
Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.
| Episode | Date |
|---|---|
|
AXPAXLI for Diabetic Retinopathy
|
May 09, 2024 |
|
NSAIDS in the treatment of Central Serous Chorioretinopathy
|
Apr 18, 2024 |
|
EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD
|
Apr 04, 2024 |
|
Intravitreal Gene Therapy for neovascular AMD with 4D-150
|
Mar 28, 2024 |
|
KSI 501 Bispecific Anti-VEGF Biopolymer Treatment of DME
|
Mar 21, 2024 |
|
Retinal Vasculitis Following Pegcetcoplan Therapy of Geographic Atrophy
|
Mar 14, 2024 |
|
High Dose Aflibercept in Severe Diabetic Macular Edema
|
Mar 07, 2024 |
|
IL-6 Inhibition in the Treatment of Uveitis Macular Edema
|
Feb 29, 2024 |
|
The High Dose Aflibercept DME Trial
|
Feb 22, 2024 |
|
The Annexon Geographic Atrophy Trial
|
Feb 15, 2024 |
|
Diagnostics for Retinoblastoma
|
Feb 08, 2024 |
|
A Feasbility Evaluating the Use of Home OCT for a Clinical Trial of Faricimab Treatment of nAMD
|
Feb 01, 2024 |
|
Visual Outcomes in the Davio Trial Looking at TKI EY-1901
|
Jan 25, 2024 |
|
A Post-Hoc Comparison of Syfovre and Izervay in Treatment of Geographic Atrophy
|
Jan 18, 2024 |
|
4 Year Results from DRCR Network Protocol W
|
Jan 11, 2024 |
|
Gene Therapy for X-Linked Retinitis Pigmentosa
|
Jan 04, 2024 |
|
Optogenetic Therapy of Inherited Retinal Degenerations
|
Dec 21, 2023 |
|
A Real World Analysis of Aflibercept Therapy of Diabetic Macular Edema
|
Dec 14, 2023 |
|
Topical Therapy of Diabetic Macular Edema
|
Dec 07, 2023 |
|
Mitochrondial Therapy of Intermediate AMD
|
Nov 30, 2023 |
|
Safety Considerations in Retinal Gene Therapy
|
Nov 16, 2023 |
|
An Oral Agent for Treatment of Diabetic Retinopathy
|
Nov 09, 2023 |
|
Intravitreal Gene Therapy with 4D-150
|
Oct 26, 2023 |
|
Optogenetics in the Treatment of Retinal Degenerations
|
Oct 19, 2023 |
|
Update on the Iluvien System for Treatment of Diabetic Macular Edema
|
Oct 12, 2023 |
|
The Ophthea Clinical Trial for Neovascular AMD
|
Oct 05, 2023 |
|
Senolytic Therapy for Diabetic Macular Edema
|
Sep 28, 2023 |
|
The Port Delivery System for Treating Diabetic Retinopathy
|
Sep 21, 2023 |
|
A Profile of Eugene de Juan, MD
|
Sep 14, 2023 |
|
An Implantation Telescope for Macular Disease
|
Aug 31, 2023 |
|
Prevention of Vision Loss in the Gather Trial of IZERVAY
|
Aug 24, 2023 |
|
GALE Long Term Extension Study for GA
|
Aug 14, 2023 |
|
Pegcetacoplan (SYFOVRE) Clinical Update
|
Aug 11, 2023 |
|
Faricimab in Neovascular AMD
|
Aug 03, 2023 |
|
High Dose Aflibercept for Neovascular AMD
|
Jul 27, 2023 |
|
Pegcetacoplan for Geographic Atrophy Update
|
Jul 20, 2023 |
|
Ocular Therapeutix: A TKI and Hydrogel Implant
|
Jul 13, 2023 |
|
Biosimilar Drugs for Retinal Diseases
|
Jul 06, 2023 |
|
Faricimab vs Aflibercept in Diabetic Macular Edema
|
Jun 29, 2023 |
|
Artificial Intelligence in the Management of Geographic Atrophy
|
Jun 22, 2023 |
|
Molecular Diagnostics in the Diagnosis and Treatment of Uveal Melanoma
|
Jun 15, 2023 |
|
Faricimab in the Treatment of Retinal Venous Occlusion
|
Jun 08, 2023 |
|
The Use of High Dose Aflibercept in Diabetic Macular Edema
|
Jun 01, 2023 |
|
Widefield OCT Angiography
|
May 25, 2023 |
|
Aflibercept Therapy of Retinopathy of Prematurity
|
May 18, 2023 |
|
Home OCT in the Management of Neovascular AMD: Latest Development
|
May 11, 2023 |
|
Suprachoroidal Corticosteroids for the Treatment of Macular Edema
|
May 04, 2023 |
|
The Use of the Port Delivery System for the Treatment of Diabetic Macular Edema
|
Apr 27, 2023 |
|
Suprachoroidal Therapy of Neovascular AMD
|
Apr 20, 2023 |
|
Microperimetry in the Assessment of Geographic Macular Atrophy
|
Apr 13, 2023 |
|
Subretinal Gene Therapy for Neovascular AMD
|
Apr 06, 2023 |
|
A Tyrosine Kinase Inhibitor Implant for the Treatment of Neovascular AMD
|
Mar 30, 2023 |
|
15 Year Results of Fixed Dose Anti-VEGF Treatment of Neovascular AMD
|
Mar 23, 2023 |
|
Dexamethasone Implant for Treating Diabetic Macular Edema
|
Mar 16, 2023 |
|
Retinal Vasculitis Update
|
Mar 02, 2023 |
|
Central Serous Chorioretinopathy
|
Feb 23, 2023 |
|
Faricimab Update
|
Feb 16, 2023 |
|
Strategies for Treatment Pauses in Neovascular AMD
|
Feb 02, 2023 |
|
Gene Therapy of Inherited Retinal Diseases
|
Jan 26, 2023 |
|
Suprachoroidal Tyrosinase Therapy of Neovascular AMD
|
Jan 12, 2023 |
|
KSI-301 (tarcocimab tedromer) therapy of Retinal Vein Occlusion
|
Jan 05, 2023 |
|
The Efficacy of Avacincaptad Pegol in Treatment of Geographic Atrophy: Gather 1 & 2 Study Results
|
Dec 15, 2022 |
|
En Face OCT, Intermediate AMD, and Georgraphic Atrophy
|
Dec 08, 2022 |
|
Safety of Pegcetacoplan in the 24 month Derby and Oaks Studies
|
Dec 01, 2022 |
|
Predominantly Peripheral Lesions on Ultra-Wide field Imaging & Risk of DR Worsening Over Time
|
Nov 17, 2022 |
|
10 Year Retrospective Review of a PHP Device for Early Detection of Neovascular AMD
|
Nov 10, 2022 |
|
Current Therapy for Venous Occlusive Disease and a Clinical Trial Involving Stem Cell Therapy for CRVO
|
Oct 27, 2022 |
|
Senolytic Therapy for Diabetic Macular Edema and Neovascular AMD
|
Oct 20, 2022 |
|
Assessment of Geographic Atrophy Lesion Progression in the Phase 3 Oaks and Derby Trials
|
Oct 13, 2022 |
|
The Role of the Clinician in Promoting Innovation
|
Oct 06, 2022 |
|
The DAVIO Study: 12 Month Results
|
Sep 22, 2022 |
|
Treat and Extend Therapy of Diabetic Macular Edema
|
Sep 15, 2022 |
|
Prophylactic IOP Lowering Measures in Anti-VEGF Injections: A Meta-Analysis
|
Sep 08, 2022 |
|
Real World Efficacy, Durability and Safety of Faricimab
|
Sep 01, 2022 |
|
New Treatments for Radiation Retinopathy
|
Aug 25, 2022 |
|
Gene Therapy of Inherited Retinal Diseases
|
Aug 18, 2022 |
|
RNA Anti Sense Therapy for Geographic Atrophy
|
Aug 11, 2022 |
|
18 Month Results of the Derby and Oaks Trials for Treatment of Geographic Atrophy
|
Aug 04, 2022 |
|
A Novel Retinal Sealant
|
Jul 28, 2022 |
|
New Developments in Imaging and Therapy of Sickle Cell Retinopathy
|
Jul 21, 2022 |
|
High Dose (8mg) Aflibercept for Treatment of Neovascular AMD
|
Jul 07, 2022 |
|
New Developments in the Management of Choroidal Melanoma
|
Jun 30, 2022 |
|
A Stem Cell Implant for the Treatment of Geographic Atrophy
|
Jun 23, 2022 |
|
DERBY and OAKS Results
|
Jun 16, 2022 |
|
Artificial Intelligence in the Management of Macular Degeneration
|
Jun 09, 2022 |
|
An Oral Agent for the Treatment of Diabetic Retinopathy
|
Jun 02, 2022 |
|
Home OCT Monitoring of Neovascular AMD Treatment
|
May 26, 2022 |
|
Faricimab in Diabetic Macular Edema: 2 Year Results of the RHINE and YOSEMITE studies
|
May 19, 2022 |
|
The Kingfisher Trial of Brolucizumab for DME
|
May 12, 2022 |
|
Subretinal Fluid in Neovascular AMD: Friend or Foe?
|
May 05, 2022 |
|
Optogenetics
|
Apr 28, 2022 |
|
Inhibition of Plasma Kallikrein in Diabetic Macular Edema
|
Apr 21, 2022 |
|
Neovascular AMD: Unpacking Surgical Disease Management Options
|
Apr 14, 2022 |
|
Ocular Therapeutics Sustained Release TKI Trial
|
Apr 07, 2022 |
|
Gene Therapy of nAMD and Diabetic Retinopathy with Dr. Allen Ho
|
Mar 31, 2022 |
|
Long Term Results of the Port Delivery System
|
Mar 24, 2022 |
|
The Altissimo Study using a TKI for nAMD
|
Mar 17, 2022 |
|
The Paladin Study of the Fluocinolone Implant Treating Diabetic Macular Edema
|
Mar 10, 2022 |
|
A Tyrosine Kinase Inhibitor that Successfully Treats nAMD
|
Mar 03, 2022 |
|
Late Breaking News on Kodiak Dazzle Trial
|
Feb 24, 2022 |
|
Suprachoroidal Gene Therapy for Neovascular AMD
|
Feb 17, 2022 |
|
Dosing with the Aflibercept Syringe
|
Feb 10, 2022 |
|
Results from the Hawk and Harrier Trials
|
Feb 03, 2022 |
|
The Susvimo Sustained Delivery System for Neovascular AMD
|
Jan 27, 2022 |
|
The Basics of Suprachoroidal Drug Delivery
|
Jan 20, 2022 |
|
Suprachoroidal Triamcinolone for Macular Edema: The Xipere System
|
Jan 05, 2022 |
|
A Profile of Pravin Dugel, MD
|
Dec 20, 2021 |
|
Elamipretide for Treatment of Geographic Atrophy
|
Nov 29, 2021 |
|
Stem Cells for the Treatment of Geographic Atrophy
|
Nov 22, 2021 |
|
Suprachoroidal Gene Therapy for Diabetic Retinopathy
|
Nov 15, 2021 |
|
Retinal Gene Therapy Surgical Techniques
|
Nov 08, 2021 |
|
Management of Retinal Vein Occlusion
|
Nov 01, 2021 |
|
Cooling Anesthesia For Intravitreal Injection
|
Oct 24, 2021 |
|
C1q Complement Blockade for Geographic Atrophy
|
Oct 11, 2021 |
|
CNTF Treatment of MacTel2
|
Oct 01, 2021 |
|
Optogenetic Therapy of Retinal Disease
|
Sep 21, 2021 |
|
Gene Therapy for Macular Neovascularization and Diabetic Retinopathy
|
Sep 08, 2021 |
|
Genetic Basis of Geographic Atrophy Treatment
|
Sep 02, 2021 |
|
Dr. Caroline Baumal with brolucizumab safety update.
|
Aug 16, 2021 |
|
Augmented Reality in Retina
|
Aug 12, 2021 |
|
Focus on Samuel Barone, MD, CMO with Gemini Therapeutics
|
Jul 12, 2021 |
|
Protocol W with Dr. Raj Maturi
|
Jun 15, 2021 |
|
Update on the PANORAMA Trial
|
Jun 03, 2021 |
|
A New Treatment Paradigm for Diabetic Macular Edema
|
Apr 27, 2021 |
|
Home OCT Monitoring of Anti-VEGF Therapy of Macular Neovascularization
|
Apr 15, 2021 |
|
Early Diagnosis of Macular Neovascularization
|
Apr 06, 2021 |
|
Dr. Diana Do Discusses Kodiak KS-301 for nAMD, DME and RVO
|
Apr 01, 2021 |
|
Focus on Dr. David Boyer of Retina Vitreous Associates Adjunct Professor, Keck School of Medicine of USC
|
Mar 07, 2021 |
|
Spotlight on Andrew Moshfeghi, MD, Associate Professor, USC Roski Eye Institute
|
Mar 07, 2021 |
|
Focus on Carl Regillo, MD, and PDS System
|
Mar 07, 2021 |
|
Focus on Arshad Khanani MD, MA Director of Clinical Services Sierra Eye Associates
|
Mar 07, 2021 |
|
Dr. Charles Wykoff Interviews Karl Csaky MD, PhD Discussing Faricimab for DME and nAMD
|
Mar 07, 2021 |
|
Focus on Cedric Francois, MD, PhD, CEO, Apellis Pharmaceuticals
|
Mar 07, 2021 |
|
Dr. Carmen Puliafito Interviews Charles Wykoff MD, PhD: Faricimab Results in DME & nAMD
|
Mar 07, 2021 |
|
Focus on Michael Goldstein , Chief Medical Officer at Ocular Therapeutix
|
Mar 06, 2021 |
|
Spotlight on David Zacks, M.D., Ph.D. Co-Founder and Chief Science Officer at ONL Therapeutics
|
Mar 06, 2021 |
|
Focus on Kourous Rezaei Chief Medical Officer at IVERIC bio
|
Mar 06, 2021 |
|
Spotlight on Dr. Adam Rogers CEO of Hemera Biosciences
|
Mar 06, 2021 |
|
Dr. Philip Rosenfeld Looks at the Future of Macular Degeneration
|
Mar 05, 2021 |
|
Dr. Philip Rosenfeld Looks at the Future of Macular Degeneration Part 2
|
Mar 05, 2021 |
|
Focus on Dr. Jay S. Duker and EyePoint Pharmaceuticals
|
Mar 04, 2021 |
|
Spotlight on Dr. Thomas Ciulla of Clearside Biomedical
|
Feb 26, 2021 |
|
Focus on Dr. Karl Csaky and Vinci Pharmaceuticals
|
Feb 26, 2021 |
|
Focus on Dr. Jason Ehrlich of Kodiak Sciences
|
Feb 26, 2021 |